Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginNet MarginOperating MarginReturn on Sales

ProQR Therapeutics (PRQR) Return on Capital Employed (2021 - 2023)

Historic Return on Capital Employed for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2023 value amounting to 0.3%.

  • ProQR Therapeutics' Return on Capital Employed rose 2400.0% to 0.3% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.3%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.27% for FY2024, which is 100.0% up from last year.
  • As of Q4 2023, ProQR Therapeutics' Return on Capital Employed stood at 0.3%, which was up 2400.0% from 0.31% recorded in Q3 2023.
  • ProQR Therapeutics' Return on Capital Employed's 5-year high stood at 0.3% during Q4 2023, with a 5-year trough of 0.58% in Q3 2022.
  • In the last 3 years, ProQR Therapeutics' Return on Capital Employed had a median value of 0.37% in 2023 and averaged 0.4%.
  • Per our database at Business Quant, ProQR Therapeutics' Return on Capital Employed tumbled by -2100bps in 2022 and then soared by 2700bps in 2023.
  • Quarter analysis of 3 years shows ProQR Therapeutics' Return on Capital Employed stood at 0.33% in 2021, then plummeted by -63bps to 0.54% in 2022, then soared by 44bps to 0.3% in 2023.
  • Its Return on Capital Employed was 0.3% in Q4 2023, compared to 0.31% in Q3 2023 and 0.37% in Q2 2023.